Bangkok project tests Same-Day hepatitis c care in community centers
NCT ID NCT05479760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a same-day approach to hepatitis C testing and treatment in community organizations in Bangkok, Thailand. It involved 200 adults who tested positive for hepatitis C antibodies. The goal was to see if offering immediate treatment with direct-acting antivirals (DAAs) at the community site, along with telehealth follow-ups, could improve the number of people who start and finish treatment compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Direct-acting antivirals (DAAs) for hepatitis C
- What this could lead to
- If successful, this approach could make hepatitis C testing and treatment faster and more accessible for high-risk communities, potentially reducing transmission.
- What could go wrong
- This is a small demonstration project (200 people) in one city, so results may not apply elsewhere. Reinfection remains possible after cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCV, HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of HIV Research and Innovation
Pathum Wan, Bangkok, 10330, Thailand
-
MPLUS Foundation (MPLUS)
Chiang Mai, 50100, Thailand
-
Rainbow Sky Association of Thailand (RSAT)
Bangkok, Bangkapi, 10240, Thailand
-
The Service Workers In Group Foundation (SWING)
Bangkok, Building 3, Patpong, Surawong Road, 10500, Thailand